Substance | <15 | 15–19 | 20–24 | 25–29 | 30–34 | 35–39 | 40–44 | 45+ | Age known | Age not known |
---|---|---|---|---|---|---|---|---|---|---|
Opiates | 10.7 | 26.4 | 44.7 | 51.9 | 53.2 | 50.4 | 49.3 | 39.5 | 37876 | 4066 |
Cocaine | 6.5 | 22.6 | 31.3 | 31.9 | 30.3 | 31.4 | 30.6 | 25.3 | 27355 | 2794 |
Stimulants | 3.1 | 6.4 | 5.0 | 4.4 | 3.8 | 3.8 | 2.6 | 2.3 | 6123 | 1699 |
Hypnotics and sedatives | 1.4 | 1.3 | 1.8 | 3.0 | 4.7 | 7.8 | 9.9 | 22.4 | 2738 | 772 |
Hallucinogens | 0.2 | 0.5 | 0.4 | 0.2 | 0.1 | 0.2 | 0.1 | 0.1 | 417 | 73 |
Volatile substances | 0.8 | 0.2 | 0.1 | 0.0 | 0.2 | 0.1 | 0.1 | 0.1 | 348 | 69 |
Cannabis | 76.5 | 41.9 | 15.9 | 7.7 | 6.2 | 5.1 | 5.6 | 6.8 | 47690 | 9352 |
Other substances | 0.9 | 0.9 | 1.0 | 1.0 | 1.4 | 1.1 | 1.9 | 3.6 | 1215 | 382 |
Total | 27164 | 51961 | 23276 | 9662 | 5568 | 2838 | 1750 | 1543 | 123762 | 19207 |
The number of treatment clients in each country is listed in Table TDI-7.
See also Table TDI-106 on distribution by country and '‘General notes for interpreting data'’ on the Explanatory notes and help page.
Reitox national reports 2012 — Table TDI — outpatient treatment centres.